End of year PBAC results today

Posted 18 December 2020 AM

The PBAC will today unveil which medicines will complete the list of recommendations for PBS listing in 2020 with major submissions dominating last month's meeting.

Although Gilead has withdrawn hyped rheumatoid arthritis drug Jyseleca, which is expected to be registered here early next year, there are still 28 major submissions, including 15 new listing requests that could potentially be handed a recommendation.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here